Wyeth researchers get Edison patent award

Wyeth researchers, Christopher P. Miller, Ph.D., Michael D. Collini, Bach D. Tran, and Arthur A. Santilli, Ph.D., received the 2006 Thomas Alva Edison Patent Award in the category of Emerging Therapies. The researchers were granted the patent for bazedoxifene, an investigational selective estrogen receptor modulator for the prevention of postmenopausal osteoporosis.

"The R&D Council of New Jersey is acknowledging the advancement of a treatment that has the potential to improve the quality of life for postmenopausal women," says Robert R. Ruffolo, Jr., Ph.D., President, Wyeth Research, and Senior Vice President, Wyeth.